COSCIENS Biopharma (TSE:CSCI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
COSCIENS Biopharma Inc., a biopharmaceutical company, has announced progress in its merger with Ceapro Inc., including management team changes and development of its product pipeline. The company is currently seeking a new President and CEO to guide future growth and is implementing cost reduction strategies, including staff cuts and program spend adjustments.
For further insights into TSE:CSCI stock, check out TipRanks’ Stock Analysis page.
